table of content
1 Study Coverage
1.1 Self-administered Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Self-administered Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injectable Drugs
1.2.3 Inhaled Drugs
1.2.4 Transdermal Drugs
1.3 Market by Application
1.3.1 Global Self-administered Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Diseases
1.3.3 Diabetes
1.3.4 Osteoporosis
1.3.5 Pain Management
1.3.6 Hormone Replacement
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Self-administered Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Self-administered Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Self-administered Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Self-administered Drugs Sales by Region
2.4.1 Global Self-administered Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Self-administered Drugs by Region (2023-2028)
2.5 Global Self-administered Drugs Revenue by Region
2.5.1 Global Self-administered Drugs Revenue by Region (2017-2022)
2.5.2 Global Self-administered Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Self-administered Drugs Sales by Manufacturers
3.1.1 Global Top Self-administered Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Self-administered Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Self-administered Drugs in 2021
3.2 Global Self-administered Drugs Revenue by Manufacturers
3.2.1 Global Self-administered Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Self-administered Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Self-administered Drugs Revenue in 2021
3.3 Global Self-administered Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Self-administered Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Self-administered Drugs Sales by Type
4.1.1 Global Self-administered Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Self-administered Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Self-administered Drugs Sales Market Share by Type (2017-2028)
4.2 Global Self-administered Drugs Revenue by Type
4.2.1 Global Self-administered Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Self-administered Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Self-administered Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Self-administered Drugs Price by Type
4.3.1 Global Self-administered Drugs Price by Type (2017-2022)
4.3.2 Global Self-administered Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Self-administered Drugs Sales by Application
5.1.1 Global Self-administered Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Self-administered Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Self-administered Drugs Sales Market Share by Application (2017-2028)
5.2 Global Self-administered Drugs Revenue by Application
5.2.1 Global Self-administered Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Self-administered Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Self-administered Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Self-administered Drugs Price by Application
5.3.1 Global Self-administered Drugs Price by Application (2017-2022)
5.3.2 Global Self-administered Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Self-administered Drugs Market Size by Type
6.1.1 North America Self-administered Drugs Sales by Type (2017-2028)
6.1.2 North America Self-administered Drugs Revenue by Type (2017-2028)
6.2 North America Self-administered Drugs Market Size by Application
6.2.1 North America Self-administered Drugs Sales by Application (2017-2028)
6.2.2 North America Self-administered Drugs Revenue by Application (2017-2028)
6.3 North America Self-administered Drugs Market Size by Country
6.3.1 North America Self-administered Drugs Sales by Country (2017-2028)
6.3.2 North America Self-administered Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Self-administered Drugs Market Size by Type
7.1.1 Europe Self-administered Drugs Sales by Type (2017-2028)
7.1.2 Europe Self-administered Drugs Revenue by Type (2017-2028)
7.2 Europe Self-administered Drugs Market Size by Application
7.2.1 Europe Self-administered Drugs Sales by Application (2017-2028)
7.2.2 Europe Self-administered Drugs Revenue by Application (2017-2028)
7.3 Europe Self-administered Drugs Market Size by Country
7.3.1 Europe Self-administered Drugs Sales by Country (2017-2028)
7.3.2 Europe Self-administered Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Self-administered Drugs Market Size by Type
8.1.1 Asia Pacific Self-administered Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Self-administered Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Self-administered Drugs Market Size by Application
8.2.1 Asia Pacific Self-administered Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Self-administered Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Self-administered Drugs Market Size by Region
8.3.1 Asia Pacific Self-administered Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Self-administered Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Self-administered Drugs Market Size by Type
9.1.1 Latin America Self-administered Drugs Sales by Type (2017-2028)
9.1.2 Latin America Self-administered Drugs Revenue by Type (2017-2028)
9.2 Latin America Self-administered Drugs Market Size by Application
9.2.1 Latin America Self-administered Drugs Sales by Application (2017-2028)
9.2.2 Latin America Self-administered Drugs Revenue by Application (2017-2028)
9.3 Latin America Self-administered Drugs Market Size by Country
9.3.1 Latin America Self-administered Drugs Sales by Country (2017-2028)
9.3.2 Latin America Self-administered Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Self-administered Drugs Market Size by Type
10.1.1 Middle East and Africa Self-administered Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Self-administered Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Self-administered Drugs Market Size by Application
10.2.1 Middle East and Africa Self-administered Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Self-administered Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Self-administered Drugs Market Size by Country
10.3.1 Middle East and Africa Self-administered Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Self-administered Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 Gilead Sciences
11.5.1 Gilead Sciences Corporation Information
11.5.2 Gilead Sciences Overview
11.5.3 Gilead Sciences Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Gilead Sciences Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Gilead Sciences Recent Developments
11.6 Antares Pharma
11.6.1 Antares Pharma Corporation Information
11.6.2 Antares Pharma Overview
11.6.3 Antares Pharma Self-administered Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Antares Pharma Self-administered Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Antares Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Self-administered Drugs Industry Chain Analysis
12.2 Self-administered Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Self-administered Drugs Production Mode & Process
12.4 Self-administered Drugs Sales and Marketing
12.4.1 Self-administered Drugs Sales Channels
12.4.2 Self-administered Drugs Distributors
12.5 Self-administered Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Self-administered Drugs Industry Trends
13.2 Self-administered Drugs Market Drivers
13.3 Self-administered Drugs Market Challenges
13.4 Self-administered Drugs Market Restraints
14 Key Findings in The Global Self-administered Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer